Sitagliptin: a potential drug for the treatment of COVID-19?
By: Sanaa K. Bardaweel, Rima Hajjo and Dima A. Sabbah
Authors
Sanaa K. Bardaweel
Department of Pharmaceutical Sciences School of Pharmacy, University of Jordan, Amman, Jordan
Rima Hajjo
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Jordan
Dima A. Sabbah
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Jordan
Language: English
Page range: 175 - 184
Accepted on: Apr 15, 2020
Published on: Nov 4, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Sanaa K. Bardaweel, Rima Hajjo, Dima A. Sabbah, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.